![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Platelet Transfusion - StatPearls - NCBI Bookshelf
2024年6月6日 · Platelet transfusion is a lifesaving procedure that prevents or stops bleeding in patients with low platelet counts or functional platelet disorders. Transfusion decisions are guided by minimum thresholds due to varying levels of platelets, with some cases not …
Platelet transfusion: Indications, ordering, and ... - UpToDate
2024年4月17日 · This topic covers the logistics of platelet use and the indications for platelet transfusion in adults. The approach to the bleeding patient, refractoriness to platelet transfusion, and platelet transfusion in neonates are discussed separately.
Platelet transfusion - Wikipedia
Platelet transfusion, is the process of infusing platelet concentrate into the body via vein, to prevent or treat the bleeding in people with either a low platelet count or poor platelet function. [1] Often this occurs in people receiving cancer chemotherapy. [1]
Platelet transfusion | The International Society of Blood ...
Platelet transfusions are indicated for actively bleeding patients with thrombocytopenia and some disorders of platelet function. There are two main underlying pathologies of platelet refractoriness: immunological and non-immunological .
How I use platelet transfusions | Blood | American Society of ...
2022年11月3日 · Platelet transfusions are commonly administered for the prevention or treatment of bleeding in patients with acquired thrombocytopenia across a range of clinical contexts. Recent data, including randomized trials, have highlighted uncertainties in the risk-benefit balance of this therapy, which is the subject of this review.
Platelet transfusions: trigger, dose, benefits, and risks - PMC
Over the last half century, platelet transfusion has been an effective therapy for the prevention and treatment of bleeding, particularly in patients with hematologic malignancies. Recent randomized trials have demonstrated that current practices may be suboptimal in …
Use general haemostatic measures to treat bleeding in patients during treatment with anti-platelet agents. If necessary, consider drug cessation and reversal of the effect of co-prescribed anticoagulants.